Driehaus Capital Management LLC Twist Bioscience Corp Transaction History

Driehaus Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$27.95 - $53.0 $4.2 Million - $7.96 Million	150,260 Added 63.03%	388,643 $19.2 Million
Q1 2024 May 15, 2024	BUY	$32.28 - $41.5 $7.7 Million - $9.89 Million	238,383 New	238,383 $8.18 Million
Q2 2021 Aug 16, 2021	SELL	$88.13 - $142.06 $10.5 Million - $16.9 Million	-119,082 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$105.48 - $207.97 $20.4 Million - $40.2 Million	-193,506 Reduced 61.9%	119,082 $14.7 Million
Q4 2020 Feb 16, 2021	SELL	$76.64 - $167.89 $10.6 Million - $23.3 Million	-138,548 Reduced 30.71%	312,588 $44.2 Million
Q3 2020 Nov 16, 2020	SELL	$45.46 - $78.79 $4.26 Million - $7.38 Million	-93,643 Reduced 17.19%	451,136 $34.3 Million
Q2 2020 Aug 14, 2020	BUY	$26.4 - $45.3 $2.55 Million - $4.38 Million	96,683 Added 21.58%	544,779 $24.7 Million
Q1 2020 May 15, 2020	BUY	$19.71 - $35.15 $1.67 Million - $2.97 Million	84,531 Added 23.25%	448,096 $13.7 Million
Q4 2019 Feb 12, 2020	BUY	$21.0 - $26.48 $116,844 - $147,334	5,564 Added 1.55%	363,565 $7.64 Million
Q3 2019 Nov 14, 2019	BUY	$23.72 - $33.99 $1.12 Million - $1.61 Million	47,312 Added 15.23%	358,001 $8.55 Million
Q2 2019 Aug 14, 2019	BUY	$21.74 - $33.2 $5.38 Million - $8.22 Million	247,615 Added 392.58%	310,689 $9.01 Million
Q1 2019 May 15, 2019	SELL	$19.95 - $27.21 $327,299 - $446,407	-16,406 Reduced 20.64%	63,074 $1.46 Million
Q4 2018 Feb 14, 2019	BUY	$14.0 - $31.08 $1.11 Million - $2.47 Million	79,480 New	79,480 $1.84 Million

256

66.6M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.68B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.